Respiratory and Fluidasa


Respiratory Symptoms and Causes

When you breathe, your lungs take in oxygen from the air and deliver it to the bloodstream. The cells in your body need oxygen to work and grow. During a normal day, you breathe nearly 25,000 times. People with lung disease have difficulty breathing. Millions of people in the U.S. have lung disease. If all types of lung disease are lumped together, it is the number three killer in the United States.

The term lung disease refers to many disorders affecting the lungs, such as asthma, COPD, infections like influenza, pneumonia and tuberculosis, lung cancer, and many other breathing problems. Some lung diseases can lead to Respiratory failure.

Dept. of Health and Human Services Office on Women's Health

Check out the latest treatments for respiratory

respiratory treatment research studies

Fluidasa clinical trials, surveys and public health registries

Find Drug Side Effect reports

Fluidasa Side Effects

Tremor (6)
Delirium (2)

➢ More

Common Meds

Abilify (10132)
Adderall (1304)
Amlodipine (6664)
Amoxicillin (4387)
Benadryl (1568)
Celebrex (12876 )
Celexa (1342)
Cialis (2975)
Cipro (8580)
Citalopram (7792)
Crestor (18839)
Cymbalta (14373)
Doxycycline (1757)
Effexor (7289)
Flexeril (435)
Flomax (2177)
Fluoxetine (4261)
Gabapentin (4593)
Hydrocodone (2469)
Ibuprofen (8222)
Lantus (10968)
Lexapro (3499)
Lipitor (17769)
Lisinopril (8919)
Lyrica (27148)
Medrol (650)
Mirena (41254)
Mobic (957)
Morphine (5356)
Naproxen (538)
Neurontin (6501)
Oxycodone (4438)
Pradaxa (13372)
Prednisone (5926)
Prilosec (2631)
Prozac (1954)
Seroquel (27216)
Simvastatin (8348)
Synthroid (4452)
Tamiflu (5585)
Topamax (3748)
Tramadol (5054)
Trazodone (1458)
Viagra (5394)
Vicodin (1153)
Wellbutrin (6324)
Xanax (2847)
Zocor (5718)

Recent Reviews

Blocked nose and waking at night with rattling in chest with inhalation

2 weeks after second infusion for Hodgkin's Lymphome (& RA), I had an extreme respiratory problem (BOOP). I was hospitalized twice & had high steroid does IV along with IV antiobiotics administered. After 1 year of decreasing steroi

5ml intramuscular morphine, produced respiratory depression, inability to communicate, severe drowsiness, low blood pressure but did not relieve the pain!


Hi, I am 42 years old and I took 900mg of chasteberry for a month and a half then stopped when I became sick with the flu and ear and respiratory infection which the doctor put me on Augmentin 875-125 for 10 days. I did not have a period at

I am taking Betaloc 50 g.since last 11 years for treatment of coronary artery disaese with Hypertension.It has done nice to me without any problem. Since it is cardioseective, it has no adverse effect on respiratory system or any side effecct related

I experienced anaphylaxis symptoms not long after one dose of z-pak. I lost my balance and fell from a short black-out, had respiratory distress and itching from hives. I had to take an antihistamine immediately and was over it in about 30 minutes.

I experienced severe nausea,convulsions,respiratory distress,abdominal pain.this was worst experience

I started taking Augmentin 875 on Tuesday evening for a respiratory infection. I got a hive on my face the first tablet taken, it dissapeared within an hour or so and since it was only one I didn't think too much of it. I then got dragging pains in m

I started taking Singulair almost 3 months ago. My Dr. was concerned w/ my frequent bouts of respiratory problems. The side effects subtly started about 2 months ago. Deep depression..restless sleeping..scattered bady pain..always tired and a total l

I started taking symbicort in december after being really sick with a upper respiratory infection and I have gained 27 pounds, I have decided to get the heck off of this drug as I originaly weighed 117 now I am up to 139 and keep on gaining the weigh

Respiratory Clinical Trials and Studies

Treatments might be new drugs or new combinations of drugs, new surgical procedures or devices, or new ways to use existing treatments. The goal of clinical trials is to determine if a new test or treatment works and is safe. Clinical trials can also look at other aspects of care, such as improving the quality of life for people with chronic illnesses. People participate in clinical trials for a variety of reasons. Healthy volunteers say they participate to help others and to contribute to moving science forward. Participants with an illness or disease also participate to help others, but also to possibly receive the newest treatment and to have the additional care and attention from the clinical trial staff.
Rank Status Study
1 Recruiting Impact of RESPIRATORY Pathogens in Infants
Condition: RESPIRATORY Tract Infection
Intervention: Device: RESPIRATORY Inductive Plethysmography
Outcome Measures: Determine the viral load of RESPIRATORY pathogens in the nasopharynx of infants with symptomatic RTIs;   Measure pulmonary function via RESPIRATORY Inductive Plethysmography (RIP) with Bronchodilator Response (BDR);   Response of lymphocytes at or near term gestation to mitogen & antigen specific responses to 1 or > viral pathogens isolated over 1st 2 yrs CGA during symptomatic & 1st yr asymptomatic RTIs via in vitro stimulation and intracellular cytokine staining;   Determine occurrence of RESPIRATORY tract symptomatic and asymptomatic viral infections weekly;   Determine the severity of illness due to viral RESPIRATORY tract infections (RTIs);   Determine rate and degree of adaptive immune system maturation utilizing flow cytometric analysis of lymphocytes in blood;   Determine occurrence and severity of asymptomatic and symptomatic RESPIRATORY tract viral infections through the first 1 and 2 years Corrected Gestational Age (CGA), respectively.;   Determine rate and degree of immune system maturation utilizing flow cytometric analysis of lymphocytes in umbilical cord blood and peripheral blood;   Determine patterns of RESPIRATORY and gut bacterial microbiome as they develop weekly;   Determine the frequency and etiology of symptomatic viral RESPIRATORY infections;   Determine if the presence of cord blood neutralizing antibodies correlates with the presence of specific antigen responses in lymphocytes;   Determine the titers of neutralizing antibodies in cord blood to isolated viral pathogens;   Measure pulmonary function via RIP with BDR;   Determine patterns of RESPIRATORY and gut bacterial microbiome as they change monthly from hospital discharge at term or near term gestation
2 Recruiting A Study in Belgian Children Hospitalized With RESPIRATORY Syncytial Virus Related Acute RESPIRATORY Infections
Condition: RESPIRATORY Syncytial Virus
Intervention: Other: No intervention
Outcome Measures: Rate of RESPIRATORY Syncytial Virus (RSV) Viral Clearance;   Change From Baseline in Clinical Symptoms Score (CSS);   Change From Baseline in Medical Support Score (MSS)
3 Recruiting A Study in Japanese Children Hospitalized With RESPIRATORY Syncytial Virus Related Lower RESPIRATORY Tract Infections
Condition: RESPIRATORY Syncytial Virus
Intervention: Biological: No intervention
Outcome Measures: Change From Baseline in RESPIRATORY Syncytial Viral Load (rate of viral clearance);   Change From Baseline in Clinical Symptoms Score (CSS);   Change From Baseline in Medical Support Score (MSS)
4 Unknown  RESPIRATORY Side Effects of Busulfan High Dose Chemotherapy in a Pediatric Population
Condition: Signs and Symptoms, RESPIRATORY
Interventions: Drug: busulfan;   Procedure: RESPIRATORY function tests;   Procedure: pharmacokinetics, done during the treatment
Outcome Measures: Determination of RESPIRATORY side effect frequency in the two years follow up of allograft or autograft treated with busulfan;   Comparison to RESPIRATORY side effect frequency with TBI conditioning regimen;   Busulfan pharmacokinetics;   Establish a potential link between RESPIRATORY side effects and busulfan pharmacokinetics
5 Recruiting Clinical and Biological Markers in Acute RESPIRATORY Failure
Conditions: Ventilator-Associated Pneumonia;   Acute RESPIRATORY Distress Syndrome
Intervention: Other: Bronchoscopy for the sampling of bronchoalveolar lavage (BAL) fluid
Outcome Measures: Change in Activin A, levels in BAL fluid from day 1 to day 5 post-enrollment;   Change in cytokine levels in BAL fluid from day 1 to day 5 post-enrollment;   Change in surfactant protein C levels in BAL fluid from day 1 to day 5 post-enrollment;   Survival to hospital discharge;   Organ Failure Free Days;   RESPIRATORY compliance and plateau airway pressure at 09:00 a.m. of days 1-10 post-enrollment;   PaO2/FiO2, PaCO2, pHa, and central-venous oxygen saturation at 09:00 a.m. of days 1-10 post-enrollment.;   Mean arterial and central-venous pressure, and norepinephrine infusion rate at 09:00 a.m. of days 1-10 post-enrollment
6 Recruiting Nutritional Intervention and RESPIRATORY Infections in Older Subjects
Conditions: Upper RESPIRATORY Infections;   Lower RESPIRATORY Tract Infections
Intervention: Dietary Supplement: Multivitamins and minerals
Outcome Measures: Incidence of RESPIRATORY infections (upper plus lower);   Mean score of DTH response to Trichophyton and tetanus toxoid;   CRP blood concentration;   Cathelicidin concentration in supernatants of cultured RESPIRATORY mucosa cells
7 Recruiting Hospital Stay and RESPIRATORY Infection
Condition: RESPIRATORY Infection
Intervention: Other: RESPIRATORY infection
Outcome Measures: Strength in upper and lower limbs;   Quality of life;   Lung function;   Activity monitoring;   Quality of sleep;   Mood
8 Recruiting RESPIRATORY Syncytial Virus - RSV Protocol
Conditions: Bone Marrow Transplant Infection;   Infection in Marrow Transplant Recipients;   RESPIRATORY Syncytial Virus Infections;   RESPIRATORY Syncytial Virus Pneumonia;   Cancer;   Acute Leukemia
Intervention: Drug: Ribavirin
Outcome Measure: Number of Participants with Progression to Lower RESPIRATORY Tract Infection (LRI)
9 Recruiting Mechanical Insufflation-Exsufflation in Preventing Post Extubation RESPIRATORY Failure in Patient With Critical Care Neuromyopathy
Conditions: Acute RESPIRATORY Insufficiency;   RESPIRATORY Failure
Interventions: Procedure: MI-E plus manually assisted coughing;   Procedure: manually assisted coughing
Outcome Measures: Incidence of RESPIRATORY failure after extubation;   the increase in peak cough flow;   the incidence of reintubation;   the average time of hospitalization in the intensive care unit;   the incidence of nasotracheal suction;   the number of additional physiotherapy sessions;   the ICU mortality or 28-day survival;   90 days survival
10 Recruiting Chest Wall Influence on RESPIRATORY System Mechanics in Morbidly Obese Patients
Conditions: Obesity;   Intra-Abdominal Hypertension
Intervention: Other: RESPIRATORY mechanics assessment
Outcome Measures: End Expiratory Lung Volumes;   RESPIRATORY mechanics;   Work of breathing;   Gas Exchange;   Gas exchange;   End Expiratory Lung Volume
11 Recruiting Long Term (1 Year) RESPIRATORY Sequelae in Children Surviving an Acute RESPIRATORY Distress Syndrome
Condition: Acute RESPIRATORY Distress Syndrome
Outcome Measure:
12 Recruiting Echocardiography Predictive of the Inefficacy and/or of the Unsafeness of Recruitment Maneuvers in Patients With Acute RESPIRATORY Distress Syndrome.
Condition: Acute RESPIRATORY Distress Syndrome
Intervention: Device: Echocardiography
Outcome Measures: Efficacy and safety of recruitment maneuvers in patients with Acute RESPIRATORY Distress Syndrome.;   Feasibility of the measurement of Longitudinal Strain and Strain Rate of the right ventricle in patients suffering from Acute RESPIRATORY Distress Syndrome.;   Comparison of the results of echocardiographic measurements between the group CONTROL and the group FAILURE.;   Evaluate the effect of the inefficacy and/or of the unsafeness of the recruitment maneuver on the future of the patient suffering from Acute RESPIRATORY Distress Syndrome.
13 Not yet recruiting Airway Inflammatory Response During Illness in Children With RESPIRATORY Failure
Conditions: Acute RESPIRATORY Failure;   Acute RESPIRATORY Infection;   Acute RESPIRATORY Distress Syndrome
Outcome Measures: Mean log transformed IL-10:IL-12p70 ratio in tracheal secretion, bronchial secretion, and serum within 48-hours of mechanical ventilation;   Blood oxygenation saturation and hemodynamic changes following non-bronchoscopic BAL;   Mean log transformed IL-10:IL-12p70 ratio in tracheal secretion, bronchial secretion, and serum between days 3-4;   Mean log transformed IL-10:IL-12p70 ratio in tracheal secretion, bronchial secretion, and serum between days 5-7
14 Unknown  RESPIRATORY Endoscopy: Diagnostic Yield, Technical Factors and Complications
Conditions: Lung Neoplasm;   Lung Diseases, Interstitial;   RESPIRATORY Tract Infections;   Pleural Effusions
Intervention: Procedure: RESPIRATORY endoscopy
Outcome Measures: Endoscopy diagnostic yield;   Endoscopy technical factors;   Endoscopy safety
15 Not yet recruiting Curosurf/Budesonide for Infants With RESPIRATORY Distress Syndrome
Condition: RESPIRATORY Distress Syndrome
Intervention: Drug: Budesonide
Outcome Measures: need of pulmonary surfactant;   the incidence of bronchopulmonary dysplasia
16 Recruiting Detecting RESPIRATORY Viruses in Upper and Lower RESPIRATORY Tract Samples
Conditions: Upper RESPIRATORY Tract Infections;   Lower RESPIRATORY Tract Infections;   Multiplex Molecular Diagnostics
Outcome Measure:
17 Recruiting Study of Vitamin D for the Prevention of Acute RESPIRATORY Infections in Children
Condition: Acute RESPIRATORY Tract Infections
Interventions: Dietary Supplement: Vitamin D3;   Dietary Supplement: Placebo
Outcome Measures: Incidence of acute RESPIRATORY tract infections;   Adverse events;   Hospitalizations due to acute RESPIRATORY tract infections;   Serum cathelicidin levels;   serum 25-hydroxyvitamin D levels;   Viral etiology of ARTIs;   Bone metabolism parameters
18 Recruiting Evaluation of a RESPIRATORY Monitor in Surgical Patients With a BMI>35
Conditions: Obesity;   Obstructive Sleep Apnea
Intervention: Device: ExSpiron RESPIRATORY Volume Monitor (RVM, ExSpiron™, RESPIRATORY Motion, Inc.; Waltham, MA
Outcome Measures: ExSpiron monitor accurately reflects TV, MV and RR in obese patients in the preoperative holding area before surgery;   ExSpiron will accurately reflect the post-extubation RESPIRATORY status of the patient
19 Not yet recruiting The Pulmonary Vascular Consequences of Divergent Strategies for Low Tidal Volume Ventilation: Hypercapnia or High RESPIRATORY Rate?
Conditions: Low Tidal Volume Ventilation;   Acute RESPIRATORY Distress Syndrome
Interventions: Other: HLR;   Other: EHR
Outcome Measures: mean pulmonary artery pressure (mPAP);   Right ventricular systolic function
20 Recruiting Validation of a Dynamic Evaluation Tool in RESPIRATORY Failure
Condition: RESPIRATORY Failure
Interventions: Device: healthy volonteers;   Device: Free breath monitoring
Outcome Measures: Number of pathological RESPIRATORY events (apneas, hypopneas, paradoxical breath) detected with regard to the recording of the PtCO2 and the SpO2;   RESPIRATORY events in healthy volonteers;   RESPIRATORY events in chronic Patients;   RESPIRATORY events in acute patients